DOCSLIB.ORG

2013 Report on Prohibited Substances

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2013 Report on Prohibited Substances 2013 REPORT ON PROHIBITED SUBSTANCES Compiled by the Racing Medication and Testing Consortium, Supervised by the Advisory Council on Equine Prohibited Substances and Practices of the IFHA Racing Medication and Testing Consortium 821 Corporate Drive, Lexington, KY 40503, USA Phone +1(859) 224-2844 Fax +1(859) 296-3033 rmtcnet.com I. RACING DAY SAMPLES TOTAL DECLARED TOTAL DECLARED BOTH BOTH DECLARED DECLARE DECLARED DECLARE POSITIVE TOTAL TOTAL TOTAL URINE URINE BLOOD BLOOD NUMBER TOTAL DECLARED TOTAL POSITIVE HORSES HORSES URINE & URINE & TOTAL TOTAL DECLARED POSITIVE D POSITIVE D CASES ON SUBSTANCES NUMBER NUMBER BOTH ONLY ONLY ONLY ONLY OF DECLARED DECLARED POSITIVE DECLARED CASES ON SAMPLED SAMPLED BLOOD BLOOD URINE BLOOD POSITIVES CASES ON POSITIVE CASES ON POSITIVE BOTH DETECTED IN COUNTRY OF RACES OF URINE & SAMPLED SAMPLED SAMPLED SAMPLED DECLARE POSITIVES POSITIVE CASES ON POSITIVE BOTH PRE- POST- SAMPLED SAMPLED ONLY ONLY POST- URINE CASES ON BLOOD CASES ON URINE & OTHER HORSE (flat & HORSES BLOOD PRE- POST- PRE- POST- D PRE-RACE CASES ON URINE PRE- CASES ON URINE & RACE RACE PRE- POST- SAMPLED SAMPLED RACE POST- BLOOD POST- BOTH BLOOD COMPETITIONS jumps) SAMPLED SAMPLED RACE RACE RACE RACE POSITIVE URINE RACE BLOOD BLOOD RACE RACE RACE PRE-RACE RACE URINE & POST- CASES PRE-RACE BLOOD RACE Argentina 5,475 11,432 199 10,930 313 116 116 Australia 19,626 45,384 17,823 27,561 70 52 17 35 18 1 17 Austria 122 34 34 18 18 16 16 0 Bahrain 26 223 223 88 88 135 135 1 1 1 Belgium 189 183 157 26 0 Brazil 5,570 5,570 414 414 4,836 4,836 320 320 63 63 50 50 11 11 2 2 Chile 4,892 6,240 6,240 5,741 5,741 499 499 6 6 4 4 2 2 China (Hong Kong) 788 12,087 9,990 2,097 2,081 0 2,081 9,888 9,888 0 118 102 16 10 6 4 10 6 4 0 0 0 0 0 0 Croatia 24 0 Cyprus 980 1,025 1,025 1,025 1,025 12 12 12 Czech Republic 479 37 37 20 20 17 17 0 Denmark France 7,346 12,621 12,621 11,156 11,156 1,465 1,465 22 22 19 19 3 3 Germany 1,275 464 4 359 101 7 4 3 Greece 794 325 325 325 325 5 5 5 5 Hungary99997070 292944 India 3,530 2,855 18 2,837 0 0 0 2,576 18 2,558 279 0 279 33 0 33 33 0 33 0 0 0 0 0 0 Ireland 349 2,623 0 2,623 1 0 1 1,943 0 1,943 679 0 679 0 0 0 0 0 0 0 0 0 0 0 0 Italy Japan (JRA) 3,454 10,374 0 10,374 0 0 0 10,125 0 10,125 249 0 249 0 0 0 0 0 0 0 0 0 0 0 0 Japan (NAR) 12,668 29,870 0 27,000 2,870 2 2 0 0 Lebanon Macau 452 1,185 246 939 777 777 408 246 162 2 22 Malaysia 10,729 8,598 2,131 2,100 2,100 1 1 8,628 8,598 30 3 2 1 2 2 Mauritius 336 3,233 2,883 350 350 350 2,883 2,883 1 1 11 Mexico 1,828 1,828 1,280 430 118 47 37 8 2 Morocco 1,938 3,472 3,472 21 21 1,724 1,724 1,727 1,727 18 18 9 9 9 9 the Netherlands 883 246 246 3 3 118 118 128 128 3 3 1 1 2 2 New Zealand 4,147 930 3,217 0 0 0 2,583 0 2,583 1,564 930 634 2 0 2 1 0 1 1 0 1 0 0 0 caffeine Norway 271 190 38 152 146 146 44 6 38 1 1 1 1 Panama 1,332 1,580 1,335 245 6 5 1 Poland 616 169 169 5 5 122 122 42 42 3 3 3 3 Qatar 452 663 663 0 0 627 627 36 36 4 4 4 4 Saudi Arabia 608 (flat) 1,019 0 796 223 14 13 1 0 Serbia282802263 2 1 Singapore 14,071 11,017 3,054 2,988 0 2,988 0 0 0 11,083 11,017 66 3 12 Slovakia 151 25 25 2 2 16 16 7 7 0 0 South Africa 4,810 328 4,482 4,204 4,204 606 328 278 6 Spain 437 422 422 34 34 369 369 99 99 8 Sweden 671 300 8 270 22 0 Switzerland 194 123 32 18 73 1 1 Tunisia 459 523 36 289 198 4 4 Turkey 10,607 298 10,309 9,313 0 9,313 1,294 298 996 27 0 27 24 0 24 3 0 3 0 0 0 United Arab Emirates 356 2,605 1,892 713 115 687 0 687 1,892 26 4 0 4 4 0 4 0 0 0 0 0 0 United Kingdom 10,146 7,523 0 7,523 624 0 624 5,308 0 5,308 1,591 0 1,591 16 0 16 14 0 14 1 0 1 1 0 1 USA 43,136 169,613 169,613 82,273 82,273 87,340 87,340 869 869 Uruguay 1,656 3,318 0 3,252 66 12 12 I. RACING DAY SAMPLES PROHIBTED SUBSTANCES DETECTED REACTION ENGENDERED COUNTRIES OF DETECTION TOTAL 2,5-Dihydroxybenzenesulfonate (component of etamsylate) Hemostatic 3-Hydroxylidocaine (metabolite of lidocaine) Local Anesthetic MEX (1) 1 3-hydroxy-N-methylmorphinan Opioid MAL (1) 1 3-OH-Lidocaine (Lidocaine metabolite) Local Anesthetic BRZ (1) 1 3-methoxytyramine 4-(Dimethylamino)-antipyrine Analgesic 4-Aminoantipyrine Analgesic 4-Methyl-Aminoantipyrine Analgesic MEX (1) 1 4-Methylamino Phenazone 5-Alpha-estrane 3-beta 17-Alpha-diol and nandrolone 6 alpha-methylprednisolone 9-carboxy-11-nor-delta-9-TCH Active principle of marijuana 16 beta-idrossistanozolol Anabolic 20-Beta-dihydro-prednisolone Glucocorticoid, Anti-Inflammatory QAT (1) 1 Aicar Blood Doping NET (1) 1 Acenocoumarol Anti-Coagulant, Vitamin K Antagonist Acepromazine Tranquilizer ARG (7), USA (2) 9 Acepromazine, flunixin Tranquilizer, Anti-Inflammatory, Analgesic Acetaminophen Analgesic IND (6), KSA (1) 7 Acetophenazine Antipsychotic Albuterol Bronchodilator Alfentanil Opioid, Analgesic USA (1) 1 Alprazolam Anxiolytic, Sedative, Muscle Relaxant (skeletal) ARG (1) 1 Altrenogest Progestogen HUN (1) 1 Ambroxol mucolytic agent Aminocaproic Acid Hemostatic ARG (1) 1 Aminorex Stimulant FRA (1) 1 Amitriptylline Tricyclic Anti-Depressant Amphetamine Stimulant AUS (1) 1 Antipyrine Antipyretic, Analgesic Arsenic Toxic element TUN (2) 2 Atenolol Beta-1 Receptor Antagonist ARG (3), IND (5), MAC (1) 9 Atenolol and Diclofenac Beta-1 Receptor Antagonist, anti-inflammatory Atropine Anticholinergic ARG (2), SIN (1), TUR (1) 4 Barbital Hypnotic BEG Benzocaine Topical Anesthetic Benzoylecgonine CNS Stimulant Benzoylecgonine ecgonine methyl ester CNS Stimulant Betamethasone Glucocorticoid, Anti-Inflammatory FRA (1), SPA (1), TUR (1) 3 Betamethasone, dexamethasone Glucocorticoid, Anti-Inflammatory Boldenone Anabolic BRZ (1), NZ (1) 2 Boldenone Sulphate (metabolite of boldenone) Anabolic CYP (1) 1 Boldenone, Flunixin Anabolic, Anti-Inflammatory, Analgesic BRZ (1) 1 Bromazepam Minor Tranquilizer ARG (2) 2 Bromhexine Expectorant, Mucolytic I. RACING DAY SAMPLES PROHIBTED SUBSTANCES DETECTED REACTION ENGENDERED COUNTRIES OF DETECTION TOTAL Bupivacaine Local Anesthetic Buspirone Anxiolytic Butazolidine, furosemide NSAID, Diuretic MEX (11) 11 ARG (1), BRZ (1), UK (1), USA Butorphanol Analgesic, Antitussive 4 (1) Butylescopolamine Antispasmodic, Muscarinic Antagonist AUS (1) 1 Butylscopolammonium Anti-Spasmodic Butylscopolammonium bromide Anti-Spasmodic BZEG (metabolite of cocaine) Local Anesthetic ARG (18), AUS (3), CHI (1), GRE (1), IND (2), JPN [NAR] (1), MAL Caffeine Cardiac & Respiratory Stimulant (2), MEX (1), MOR (1), PAN (4), 49 KSA (1), TUR (5), UAE (1), USA (4) URU (4) Caffeine, Mephentermine Caffeine nikethamide Cardiac & Respiratory Stimulant Caffeine metabolites Cardiac & Respiratory Stimulant BRZ (1) 1 Caffeine, Clenbuterol, Firocoxib Cardiac & Respiratory Stimulant; Antihistaminic, Antipruritic, Sedative; Caffeine, cyproheptadine, paraxantheme, theophylline Vasodilator, Diuretic Cardiac & Respiratory Stimulant, Glucocorticoid, Anti-Inflammatory, Caffeine, Dexametasone, 4-Aminoantipyrine, 4-Methyl-Aminoantipyrine MEX (1) 1 Analgesic Cardiac & Respiratory Stimulant, Myocaridal Stimulant, Vasodilator, Caffeine, theobromine, theophylline Diuretic Caffeine, theophylline Cardiac & Respiratory Stimulant, Vasodilator, Diuretic BRZ (1), TUR (3) 4 AUS (1), FRA (2), HUN (1), NET Capsaicin Topical Analgesic 8 (1), QAT (2), TUN (1) Capsaicin, dihydrocapsaicin Topical Analgesic Carbazochrome Antihemorrhagic MEX (4), TUR (2) 6 Carisoprodol Muscle Relaxant USA (1) 1 Cetirizine Anti-Histamine Chlorpropamide Antidiabetic Chlorpheniramine Antiallergic Agent, Antihistaminic MEX (1) 1 Chlorpromazine Antipsychotic ARG (1) 1 Chlorothiazide Cimetidine Anti-Ulcerative FRA (1) 1 Clanobutin Apetite Stimulant ARG (23), AUS (2), BRZ (9), Clenbuterol Bronchodilator MEX (8), KSA (3), UK (1), USA 49 (3) Clenbuterol, dembrexine Bronchodilator, Expectorant, Mucolytic Clenbuterol, Firocoxib, Ketoprofen Clenbuterol, formoterol, heptaminol, furosemide, phenylbutazone, mono-hydroxylated, stanozolol Bronchodilator; Cardiotonic; Diuretic; Analgesic, Anti-Inflammatory; metabolite Anabolic Steroid Clenbuterol, Ractopamine Bronchodilator, Beta-2 Adrenoceptor Agonist, Growth Stimulant MEX (1) 1 Clonixin Analgesic, Antipyretic, NSAID ARG (2) 2 Cocaine CNS Stimulant, Topical Anesthetic ARG (3), CHI (2) 5 Codeine Opioid Analgesic, Antitussive, Antidiarrheal Cortivazol Glucocorticoid I. RACING DAY SAMPLES PROHIBTED SUBSTANCES DETECTED REACTION ENGENDERED COUNTRIES OF DETECTION TOTAL Cromolyn Anti-Bleeder USA (2) 2 Cyproheptadine Antihistaminic, Antipruritic, Sedative ARG (1), BRZ (1) 2 Darbepoetin EPO Stimulanting Agent USA (1) 1 Dehydronorketamine, norketamine, ketamine Local Anesthetic, Analgesic Dembrexine Expectorant, Mucolytic ARG (10), AUS (2), BRZ (5), FRA (3), KSA (1), SER (3), SPA (1), Dexamethasone Glucocorticoid, Anti-Inflammatory 33 TUN (1), TUR (2), UK (1), USA (3), URU (1) Dexamethasone, diclofenac Glucocorticoid, Anti-Inflammatory Dextromethorphan Antitussive Dextropropoxyphene Analgesic ARG (1) 1 Detomidine Sedative, Analgesic Diazepam Anxiolytic, Sedative, Muscle Relaxant (skeletal) ARG (2), BRZ (1), MOR (1), UAE Diclofenac Anti-Inflammatory 6 (1), USA (1) Di-isopropylamine Dichloroacetate Vasodilator Dimethyl Sulfoxide Anti-Inflammatory, Analgesic HUN (1) 1 Diphenhydramine Anti-Histamine ARG (1) 1 Dipyrone Analgesic, Antispasmodic ARG (7), MOR (1), TUR (2) 10 Dipyrone, Phenylbutazone Analgesic, Antispasmodic, Anti-Inflammatory BRZ (1) 1 Dyphylline Bronchodilator Ephedrine Sympathomimetic Agent, Bronchodilator ARG (6) 6 Ephedrine, phenylpropanolamine, pseudoephedrine Ergonovine Reduces uterine bleeding after delivery GRE (1), MEX (1) 2 Estranediol Anabolic, androgenic steroid SPA (1) 1
Load more

Recommended publications
  • Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers with Topical Pharmaceutical Agents
    Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents Author Watts, Annabelle M, Cripps, Allan W, West, Nicholas P, Cox, Amanda J Published 2019 Journal Title FRONTIERS IN PHARMACOLOGY Version Version of Record (VoR) DOI https://doi.org/10.3389/fphar.2019.00294 Copyright Statement © Frontiers in Pharmacology 2019. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version. Downloaded from http://hdl.handle.net/10072/386246 Griffith Research Online https://research-repository.griffith.edu.au fphar-10-00294 March 27, 2019 Time: 17:52 # 1 REVIEW published: 29 March 2019 doi: 10.3389/fphar.2019.00294 Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents Annabelle M. Watts1*, Allan W. Cripps2, Nicholas P. West1 and Amanda J. Cox1 1 Menzies Health Institute Queensland, School of Medical Science, Griffith University, Southport, QLD, Australia, 2 Menzies Health Institute Queensland, School of Medicine, Griffith University, Southport, QLD, Australia Allergic rhinitis (AR) is a chronic upper respiratory disease estimated to affect between 10 and 40% of the worldwide population. The mechanisms underlying AR are highly complex and involve multiple immune cells, mediators, and cytokines. As such, the development of a single drug to treat allergic inflammation and/or symptoms is confounded by the complexity of the disease pathophysiology. Complete avoidance of allergens that trigger AR symptoms is not possible and without a cure, the available therapeutic options are typically focused on achieving symptomatic relief.
    [Show full text]
  • NEWS..2,3 What's
    Club no. 16150 Vol. 54 no. 16 Saturday, 5th December, 2020 President : Aloke Kumar Kanodia Secretary : Amar Kumar Malhotra Editor : Ajay Khanna ....2 DECEMBER IS DISEASE PREVENTION Event ....2 AND TREATMENT MONTH Minutes ... 2 What’s NE WS ..2,3 Glimpses of Joint Meeting with Rotary Club of Singapore Heartlands Topic: A I Technology in Medical Facilities District Foundation Seminar at a glance Contd ... page 2 Trustee chair’s message - December 2020 On a foggy Christmas Eve in Victorian London, the old miser people we have never met and will sits at his desk. never see, for those who are not so Bitter and disillusioned with the world, Ebenezer Scrooge has fortunate as we and could use a helping only one interest: his bottom line. He declines his nephew’s hand. The miracle of giving that Scrooge invitation to Christmas dinner, refuses to support the poor discovered on Christmas Eve is exactly and deprived, and reluctantly grants his underpaid clerk, Bob what The Rotary Foundation does 365 Cratchit, time off for Christmas Day. days a year. After he arrives home, strange things begin to happen. Jacob Our Foundation serves simultaneously as charity and performer Marley, his deceased business partner, appears as a ghost in the field; Rotarians are on the ground, volunteering their tethered to a chain, telling Scrooge to change his self-centered skills and business expertise in support of grants that are ways, lest he meet the same fate. funded by you. In this way, we carry out some of Rotary’s most important work, such as protecting mothers and their That is the premise of A Christmas Carol, Charles Dickens’ babies and helping communities recover from the shocks of classic tale of a man’s transformation from hardened recluse to COVID-19.
    [Show full text]
  • (CD-P-PH/PHO) Report Classification/Justifica
    COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) Report classification/justification of medicines belonging to the ATC group R01 (Nasal preparations) Table of Contents Page INTRODUCTION 5 DISCLAIMER 7 GLOSSARY OF TERMS USED IN THIS DOCUMENT 8 ACTIVE SUBSTANCES Cyclopentamine (ATC: R01AA02) 10 Ephedrine (ATC: R01AA03) 11 Phenylephrine (ATC: R01AA04) 14 Oxymetazoline (ATC: R01AA05) 16 Tetryzoline (ATC: R01AA06) 19 Xylometazoline (ATC: R01AA07) 20 Naphazoline (ATC: R01AA08) 23 Tramazoline (ATC: R01AA09) 26 Metizoline (ATC: R01AA10) 29 Tuaminoheptane (ATC: R01AA11) 30 Fenoxazoline (ATC: R01AA12) 31 Tymazoline (ATC: R01AA13) 32 Epinephrine (ATC: R01AA14) 33 Indanazoline (ATC: R01AA15) 34 Phenylephrine (ATC: R01AB01) 35 Naphazoline (ATC: R01AB02) 37 Tetryzoline (ATC: R01AB03) 39 Ephedrine (ATC: R01AB05) 40 Xylometazoline (ATC: R01AB06) 41 Oxymetazoline (ATC: R01AB07) 45 Tuaminoheptane (ATC: R01AB08) 46 Cromoglicic Acid (ATC: R01AC01) 49 2 Levocabastine (ATC: R01AC02) 51 Azelastine (ATC: R01AC03) 53 Antazoline (ATC: R01AC04) 56 Spaglumic Acid (ATC: R01AC05) 57 Thonzylamine (ATC: R01AC06) 58 Nedocromil (ATC: R01AC07) 59 Olopatadine (ATC: R01AC08) 60 Cromoglicic Acid, Combinations (ATC: R01AC51) 61 Beclometasone (ATC: R01AD01) 62 Prednisolone (ATC: R01AD02) 66 Dexamethasone (ATC: R01AD03) 67 Flunisolide (ATC: R01AD04) 68 Budesonide (ATC: R01AD05) 69 Betamethasone (ATC: R01AD06) 72 Tixocortol (ATC: R01AD07) 73 Fluticasone (ATC: R01AD08) 74 Mometasone (ATC: R01AD09) 78 Triamcinolone (ATC: R01AD11) 82
    [Show full text]
  • Daily Cause List for 07.01.2021
    Appellate Jurisdiction Daily Supplementary List Of Cases For Hearing On Thursday, 7th of January, 2021 CONTENT SL COURT PAGE BENCHES TIME NO. ROOM NO. NO. HON'BLE CHIEF JUSTICE THOTTATHIL B. 1 On 07-01-2021 1 RADHAKRISHNAN 1 DB -I At 10:45 AM HON'BLE JUSTICE ARIJIT BANERJEE 16 On 07-01-2021 2 HON'BLE JUSTICE RAJESH BINDAL 10 HON'BLE JUSTICE ANIRUDDHA ROY DB - II At 10:45 AM HON'BLE JUSTICE I. P. MUKERJI 3 On 07-01-2021 3 16 HON'BLE JUSTICE MD. NIZAMUDDIN DB - III At 10:45 AM HON'BLE JUSTICE HARISH TANDON 2 On 07-01-2021 4 19 HON'BLE JUSTICE KAUSIK CHANDA DB- IV At 10:45 AM HON'BLE JUSTICE SOUMEN SEN 12 On 07-01-2021 5 25 HON'BLE JUSTICE SAUGATA BHATTACHARYYA DB-V At 10:45 AM HON'BLE JUSTICE SUBRATA TALUKDAR 5 On 07-01-2021 6 28 HON'BLE JUSTICE SUBHASIS DASGUPTA DB - VI At 10:45 AM 25 On 07-01-2021 7 HON'BLE JUSTICE TAPABRATA CHAKRABORTY 39 SB - I At 10:45 AM 4 On 07-01-2021 8 HON'BLE JUSTICE ARINDAM SINHA 47 SB - II At 10:45 AM HON'BLE JUSTICE DEBANGSU BASAK 36 On 07-01-2021 9 60 HON'BLE JUSTICE DEBANGSU BASAK SB - III At 10:45 AM 38 On 07-01-2021 10 HON'BLE JUSTICE ASHIS KUMAR CHAKRABORTY 64 SB - IV At 10:45 AM 30 On 07-01-2021 11 HON'BLE JUSTICE SHIVAKANT PRASAD 73 SB - V At 10:45 AM 13 On 07-01-2021 12 HON'BLE JUSTICE RAJASEKHAR MANTHA 77 SB - VI At 10:45 AM 8 On 07-01-2021 13 HON'BLE JUSTICE SABYASACHI BHATTACHARYYA 93 SB - VII At 10:45 AM 26 On 07-01-2021 14 HON'BLE JUSTICE SHEKHAR B.
    [Show full text]
  • Rhinitis - Allergic (1 of 15)
    Rhinitis - Allergic (1 of 15) 1 Patient presents w/ signs & symptoms of rhinitis 2 • Consider other classifi cations of rhinitis DIAGNOSIS No - Please see Rhinitis Is allergic rhinitis - Nonallergic disease confi rmed? management chart Yes 3 ASSESS DURATION & SEVERITY OF ALLERGIC RHINITIS A Non-pharmacological therapy • Allergen avoidance • Patient education VAS <5 VAS ≥5 B Pharmacological therapy B Pharmacological therapy • Antihistamines (oral/nasal), &/or • Corticosteroids (nasal), w/ or without • Corticosteroids (nasal), or • Antihistamines (nasal), or • Cromone (nasal), or • LTRA • Leukotriene receptor antagonists (LTRA)MIMS TREATMENT © See next page Specifi cally for patients w/ asthma Not all products are available or approved for above use in all countries. Specifi c prescribing information may be found in the latest MIMS. B167 © MIMS Pediatrics 2020 Rhinitis - Allergic (2 of 15) Previously treated symptomatic Previously treated symptomatic patient (VAS <5) on antihistamines patient (VAS ≥5) on intensifi ed (oral/nasal) &/or corticosteroids (nasal) therapy w/ corticosteroids (nasal) w/ or without antihistamines (nasal) Intermittent Persistent symptoms, symptoms or without allergen w/ allergen exposure exposure B Pharmacological therapy B Pharmacological therapy • Step down or discontinue therapy • Continue or step up therapy Untreated REASSESS DISEASE SEVERITY VAS symptomatic patient DAILY UP TO DAY 3 (VAS <5 or ≥5) 4 CONTINUE Yes THERAPY & STEP EVALUATION VAS <5 DOWN THERAPY1 Improvement of symptoms? No VAS ≥5 B Pharmacological therapy • Step-up therapy REASSESS DISEASE SEVERITY MIMSVAS DAILY UP TO DAY 7 4 Yes EVALUATION VAS <5 Improvement of symptoms? No TREATMENT © VAS ≥5 See next page Continue therapy if symptomatic; consider step-down or discontinuation of therapy if symptoms subside Not all products are available or approved for above use in all countries.
    [Show full text]
  • Prohibited Substances List
    Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR). Neither the List nor the EADCM Regulations are in current usage. Both come into effect on 1 January 2010. The current list of FEI prohibited substances remains in effect until 31 December 2009 and can be found at Annex II Vet Regs (11th edition) Changes in this List : Shaded row means that either removed or allowed at certain limits only SUBSTANCE ACTIVITY Banned Substances 1 Acebutolol Beta blocker 2 Acefylline Bronchodilator 3 Acemetacin NSAID 4 Acenocoumarol Anticoagulant 5 Acetanilid Analgesic/anti-pyretic 6 Acetohexamide Pancreatic stimulant 7 Acetominophen (Paracetamol) Analgesic/anti-pyretic 8 Acetophenazine Antipsychotic 9 Acetylmorphine Narcotic 10 Adinazolam Anxiolytic 11 Adiphenine Anti-spasmodic 12 Adrafinil Stimulant 13 Adrenaline Stimulant 14 Adrenochrome Haemostatic 15 Alclofenac NSAID 16 Alcuronium Muscle relaxant 17 Aldosterone Hormone 18 Alfentanil Narcotic 19 Allopurinol Xanthine oxidase inhibitor (anti-hyperuricaemia) 20 Almotriptan 5 HT agonist (anti-migraine) 21 Alphadolone acetate Neurosteriod 22 Alphaprodine Opiod analgesic 23 Alpidem Anxiolytic 24 Alprazolam Anxiolytic 25 Alprenolol Beta blocker 26 Althesin IV anaesthetic 27 Althiazide Diuretic 28 Altrenogest (in males and gelidngs) Oestrus suppression 29 Alverine Antispasmodic 30 Amantadine Dopaminergic 31 Ambenonium Cholinesterase inhibition 32 Ambucetamide Antispasmodic 33 Amethocaine Local anaesthetic 34 Amfepramone Stimulant 35 Amfetaminil Stimulant 36 Amidephrine Vasoconstrictor 37 Amiloride Diuretic 1 Prohibited Substances List This is the Equine Prohibited Substances List that was voted in at the FEI General Assembly in November 2009 alongside the new Equine Anti-Doping and Controlled Medication Regulations(EADCMR).
    [Show full text]
  • 7-Nose II.Docx ( Updated F1 )
    1 [Color index: Important | Notes | Extra] Editing ​ ​ ​ ​ ​ ​ ​ ​ 2 Diseases of the nose Supernumerary nostril Midline nasal sinus: Nasal clefts: Proboscis lateralis: Incomplete fusion of the right Failure of frontal nasal Due to imperfect fusion and left medial nasal process to develop between the maxillary process prominence. appropriately results into and the lateral nasal process. two separated halves of the nose. Polyrrhinia: Arrhinia: due to bilateral Half nose: due to unilateral absence of nasal placode ​ ​ Duplication of the medial nasal absence of nasal placodes. processes. This is serious because the newborn is a nose breather. mouth breathing is a learning process. Atresia of posterior nares ❖ Types: ● Bony (most commonly) ● Membranous ● Mixed ● Complete unilateral (most commonly) ● Complete bilateral surgical emergency ​ ● Incomplete unilateral ● Incomplete bilateral ❖ Diagnosis: ● Total absence of nasal air flow ● Plastic catheter cannot be passed through the nose ● Post-rhinoscopy ● Radiographs 3 ● Emergency ● Transnasal perforation ● Trans-palatal excision ❖ Management: ﻧﻔﺘﺢ ﻓﻤﻪ ﻓﯿﻀﻄﺮ ﯾﺘﻨﻔﺲ ﻣﻦ ﻓﻤﻪ (Put something to open the mouth (oral airway ● ● Perforate it If membranous ● Surgery (endoscopic) ● In bilateral it is an emergency, in unilateral it is not an emergency and we can wait until the child gains weight then we do surgery. ● Rhinitis refers to inflammatory changes in the nasal mucosa. As the nasal mucosa is continuous ​ ​ ​ ​ ​ ​ over the nose and sinuses, there is nearly always some inflammatory change in the sinuses as 1 well. Hence Rhinosinusitis is​ a better term. ● Types: - acute rhinitis (less than 4 weeks) - chronic rhinitis (more than four consecutive weeks) ● Types based on etiology: 1) Infectious rhinitis(viral/bacterial) 2)Non-allergic Rhinitis,Non-infectious rhinitis -Eosinophilic syndromes(Nares/Nasal polyposis) -NonEosinophilic syndromes(Vasomotor rhinitis/Rhinitis medicamentosa/occupational rhinitis/Rhinitis of pregnancy/hypothyroidism/Medication(OCP).
    [Show full text]
  • Quarterly Newsletter
    January-March 2020 Quarterly Newsletter Kolkata Mary Ward Social Centre 1, Convent Lane, Tangra, Kolkata-700015, West Bengal, India Newsletter for Jan-Mar 2020 (For private circulation only) Page 1 KMWSC stands firm towards its commitment even at times of global crisis The outbreak of CORONA and the WHO declaring it as a global pandemic affecting mankind throughout the world. The world witnessed hundreds of death on a daily basis. In the absence of any vaccine for COVID-19, the only option is to prevent the virus from spreading through social distancing as announced by the Indian Government. In its effort to prevent the virus from spreading into the community, the State Government declared a total lock rd in West Bengal for a period of seven days starting 23 March, 2020. This was followed by a nationwide lock down order from the Central Government for a period of 14 days, which was further extended to 21 days. This lock down can be extended even further depending on the situations. As of now, the future is very uncertain. Field level activities of every project of Kolkata Mary Ward Social Centre have been immensely affected owing to the global pandemic. As a socially responsible Organization, KMWSC has to take every step that it can prevent the spread of COVID-19. To create social distancing, classes at our Brick Field Schools in Nadia, North & South 24 Parganas have to be suspended. Our Multi Activity Centres (MAC) all over Kolkata has also been shut down. The centre serving children of commercial sex workers and their mothers in Sonagachhi is also closed.
    [Show full text]
  • Rhinitis (415) 833-3780
    Department of Allergy, Asthma & Immunology Kaiser Permanente San Francisco 1635 Divisadero Street, Suite 101 San Francisco, California 94115 RHINITIS (415) 833-3780 RHINITIS Nasal congestion, runny nose, sneezing, itching, post nasal drip, and sometimes headache are signs of a sensitive and inflamed nose or rhinitis. Rhinitis affects more than 40 million people in the United States. Rhinitis can be allergic or non-allergic. Allergy testing will help differentiate between allergic and non-allergic rhinitis. In addition, allergic rhinitis and non-allergic rhinitis can be present in the same person. ALLERGIC RHINITIS Allergic rhinitis is caused by allergens such as pollens, dust mite, animal dander or mold. Seasonal allergies caused by airborne pollens occur during spring, summer and fall. In contrast, allergies that can occur at any time of the year are caused by indoor allergens such as house dust mite, animals and mold. Eye symptoms, such as itching, tearing, red eye as well as asthma may be present with allergic rhinitis. Testing can be helpful in identifying both seasonal and non-seasonal allergens. For further help on controlling your allergies, please refer to the brochure, Controlling Your Airborne Allergies. Management of Allergic Rhinitis 1. Avoid allergens when possible. 2. Medical Management. The first line of medical therapy is nasal inhaled steroids. Oral medications like antihistamines and decongestants and can be helpful. If you want to use decongestants, you need to discuss their use with your provider. Other medications may be considered by your provider as well. 3. Allergy immunotherapy (shots) may be an option for some patients. NON-ALLERGIC RHINITIS If it isn’t an allergy, what is it? If it isn’t an allergy, most likely it is a condition that mimics allergic rhinitis, known as vasomotor rhinitis.
    [Show full text]
  • Appellate Jurisdiction
    Appellate Jurisdiction Daily Supplementary List Of Cases For Hearing On Thursday, 18th of February, 2021 CONTENT SL COURT PAGE BENCHES TIME NO. ROOM NO. NO. HON'BLE CHIEF JUSTICE THOTTATHIL B. 1 On 18-02-2021 1 RADHAKRISHNAN 1 DB -I At 10:45 AM HON'BLE JUSTICE ARIJIT BANERJEE HON'BLE JUSTICE RAJESH BINDAL 16 On 18-02-2021 2 21 HON'BLE JUSTICE ANIRUDDHA ROY DB - II At 10:45 AM HON'BLE JUSTICE I. P. MUKERJI 37 On 18-02-2021 3 37 HON'BLE JUSTICE MD. NIZAMUDDIN DB - III At 10:45 AM HON'BLE JUSTICE I. P. MUKERJI 3 On 18-02-2021 4 38 HON'BLE JUSTICE MD. NIZAMUDDIN DB - III At 10:45 AM HON'BLE JUSTICE HARISH TANDON 2 On 18-02-2021 5 42 HON'BLE JUSTICE KAUSIK CHANDA DB- IV At 10:45 AM HON'BLE JUSTICE SUBRATA TALUKDAR 11 On 18-02-2021 6 52 HON'BLE JUSTICE SAUGATA BHATTACHARYYA DB - VI At 10:45 AM HON'BLE JUSTICE TAPABRATA CHAKRABORTY 28 On 18-02-2021 7 56 HON'BLE JUSTICE TIRTHANKAR GHOSH DB - VII At 10:45 AM 28 1 -02-2021 8 HON'BLE JUSTICE TAPABRATA CHAKRABORTY For 9 77 SB - I At 03:00 PM HON'BLE JUSTICE ARINDAM SINHA 4 On 18-02-2021 9 80 HON'BLE JUSTICE SUVRA GHOSH DB - VIII At 10:45 AM 4 On 18-02-2021 10 HON'BLE JUSTICE ARINDAM SINHA 87 SB - II At 03:00 PM 38 On 18-02-2021 11 HON'BLE JUSTICE ARIJIT BANERJEE 90 SB At 10:45 AM 36 On 18-02-2021 12 HON'BLE JUSTICE DEBANGSU BASAK 116 SB - I At 02:00 PM 13 On 18-02-2021 13 HON'BLE JUSTICE RAJASEKHAR MANTHA 119 SB - III At 10:45 AM 8 On 18-02-2021 14 HON'BLE JUSTICE SABYASACHI BHATTACHARYYA 132 SB - IV At 10:45 AM 39 On 18-02-2021 15 HON'BLE JUSTICE MOUSHUMI BHATTACHARYA 156 SB - VI At 10:45 AM 15 On 18-02-2021 16 HON'BLE JUSTICE RAJARSHI BHARADWAJ 157 SB - VII At 10:45 AM 19 On 18-02-2021 17 HON'BLE JUSTICE SHAMPA SARKAR 194 SB - VIII At 10:45 AM SL NO.
    [Show full text]
  • Agreement for Sale
    AGREEMENT FOR SALE This Agreement for Sale (Agreement) executed on this _____________ day of ____________, 2019 By and Between (1) DAMODAR ROPEWAYS & INFRA LIMITED, (formerly known as Indian Ropeways & Engineering Company Limited) (PAN No. AAACI5764L and CIN No. U51397WB1981PLC034211) a Company within the meaning of the Companies Act, 2013 having its registered office at No. 1/A, Vansittart Row, Police Station Hare Street, Kolkata 700 001, (2) ACCURATE REAL ESTATES PRIVATE LIMITED, (PAN No. AAGCA2100E and CIN No. U45200WB2007PTC113875) a Company within the meaning of the Companies Act, 2013 having its registered office at No. 45, Vivekanand Road, Police Station Girish Park, Kolkata 700 007, (3) SPLASH PROPERTIES PRIVATE LIMITED, (PAN No. AAKCS6833J and CIN No. U45200WB2007PTC113965) a Company within the meaning of the Companies Act, 2013 having its registered office at No. 2, Rowland Road, Police Station Ballygunge, Kolkata 700 020, (4) ABUNDANT PROPERTIES LLP, (PAN No. ABLFA1479M and LLP Identification No. AAL-9869) (formerly known as Abundant Properties Private Limited) a Limited Liability Partnership under the Limited Liability Partnership Act, 2008 having its registered office at No. 6/2, Moira Street, Police Station Shakespeare Sarani, Kolkata 700 017, (5) SEED PROPERTIES PRIVATE LIMITED, (PAN No. AAKCS6832K and CIN No. U45200WB2007PTC113870) a Company within the meaning of the Companies Act, 2013 having its registered office situated at No. 1/A, Vansittart Row, Police Station Hare Street, Kolkata 700 001, (6) KING PROPERTIES PRIVATE LIMITED, (PAN No. AADCK0301J and CIN No. U45200WB2007PTC114036) a Company within the meaning of the Companies Act, 2013 having its registered office at No. 6A, Tiljola Road, Police Station Tiljola, Kolkata 700 046, (7) MASON BUILDCON PRIVATE LIMITED , (PAN No.
    [Show full text]
  • KR Lakshmanan
    http://JUDIS.NIC.IN SUPREME COURT OF INDIA Page 1 of 28 PETITIONER: DR. K.R. LAKSHMANAN Vs. RESPONDENT: STATE OF TAMIL NADU AND ANR. DATE OF JUDGMENT: 12/01/1996 BENCH: KULDIP SINGH (J) BENCH: KULDIP SINGH (J) HANSARIA B.L. (J) MAJMUDAR S.B. (J) CITATION: 1996 AIR 1153 1996 SCC (2) 226 JT 1996 (1) 173 1996 SCALE (1)208 ACT: HEADNOTE: JUDGMENT: WITH [W.P(C) Nos.726, 1361 of 1986, 1053/87, 1028/86, 666/86, 1067/86, 1491/86, 923/86, I.A.3/92 in W.P(C) No.857/86, C.A.1715/75, CMP No.21945/86, 14162/86, 20859 & 24540 of 1986] J U D G M E N T Kuldip Singh, J. The Madras Race Club (the club) is an Association registered as a company with limited liability under the Companies Act, 1956. The club was formed in the year 1896 by taking over the assets and liabilities of the erstwhile unincorporated club known as Madras Race Club. According to its Memorandum and Articles of Association, the principal object of the club is to carry on the business of a race club in the running of horse races. The club is one of the five "Turf Authorities of India", the other four being the Royal Calcutta Turf Club, the Royal Western India Turf Club Limited, the Bangalore Turf Club LImited and the Hyderabad Race Club. Race meetings are held in the club's own race course at Madras and at Uthagamandalam (Ooty) for which bets are made inside the race course premises.
    [Show full text]